(NASDAQ:YMTX) shares are up more than 40% in the pre-market on more than 23,000 trades on Acquisition news. Currently at $1.98

June 6, 2022

Yumanity Therapeutics, Inc.(Yumanity) (Nasdaq:YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced it has entered into definitive agreements for two strategic transactions.

https://sports.yahoo.com/yumanity-therapeutics-announces-definitive-agreements-103000748.html

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.